Increased genetic risk for obesity in premature coronary artery disease

[1]  Anne Tybjærg-Hansen,et al.  Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators From Obesity to Ischemic Heart Disease , 2015, Circulation research.

[2]  John Spertus,et al.  Inactivating mutations in NPC1L1 and protection from coronary heart disease. , 2014, The New England journal of medicine.

[3]  K. Leander,et al.  FTO Genotype, Physical Activity, and Coronary Heart Disease Risk in Swedish Men and Women , 2014, Circulation. Cardiovascular genetics.

[4]  Talicia Tarver,et al.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[6]  N. Timpson,et al.  The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach , 2012, PLoS medicine.

[7]  Nilesh J Samani,et al.  A Genome-Wide Association Study for Coronary Artery Disease Identifies a Novel Susceptibility Locus in the Major Histocompatibility Complex , 2012, Circulation. Cardiovascular genetics.

[8]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[9]  Yurii S. Aulchenko,et al.  PredictABEL: an R package for the assessment of risk prediction models , 2011, European Journal of Epidemiology.

[10]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[11]  N. Cook,et al.  The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. , 2010, American heart journal.

[12]  J. Pitha,et al.  A FTO variant and risk of acute coronary syndrome. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[13]  R. McPherson,et al.  Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. , 2010, Journal of the American College of Cardiology.

[14]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[15]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[16]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[17]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[18]  J. Polak,et al.  Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. , 1999, Archives of internal medicine.

[19]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[20]  Inactivating Mutations in NPC 1 L 1 and Protection from Coronary Heart Disease , 2014 .

[21]  D. Strachan,et al.  Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture , 2013 .

[22]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[23]  Eric Boerwinkle,et al.  Sequence Variations in PCSK 9 , Low LDL , and Protection against Coronary Heart Disease , 2006 .